Table 4.
Hypoglycemic drug/diet therapy |
All patients |
GIR 5–10 mg·kg–1·min–1 |
||
---|---|---|---|---|
(n = 15) |
(n = 10) |
|||
Partial r | P | Partial r | P | |
All drugs |
0.854 |
< 0.0001 |
0.917 |
< 0.0001 |
Biganide |
0.830 |
< 0.0001 |
0.902 |
< 0.0001 |
Sulfonylurea |
0.839 |
< 0.0001 |
0.949 |
< 0.0001 |
DPP4 inhibitor |
0.834 |
< 0.0001 |
0.896 |
< 0.0001 |
Glinide |
0.833 |
< 0.0001 |
0.886 |
< 0.0001 |
α-GI |
0.793 |
0.001 |
0.889 |
< 0.0001 |
Diet therapy alone | 0.854 | < 0.0001 | 0.917 | < 0.0001 |
Correlations between 20/(F-CPR × FPG) and GIR were adjusted for all drugs or for individual drugs.
DPP4 dipeptidyl peptidase 4, GI glucosidase inhibitor.